Dr. Ben Viglianti, M.D, Ph.D.
Claim this profileClinical Trials Ben Viglianti, M.D, Ph.D. is currently running
More about Ben Viglianti, M.D, Ph.D.
Clinical Trial Related
5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Ben Viglianti, M.D, Ph.D. has experience with
- [18F]FNP-59
Breakdown of trials Ben Viglianti, M.D, Ph.D. has run
Hypertension
High Blood Pressure
High Cholesterol
Radiotracer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ben Viglianti, M.D, Ph.D. specialize in?
Ben Viglianti, M.D, Ph.D. focuses on Hypertension and High Blood Pressure. In particular, much of their work with Hypertension has involved treating patients, or patients who are undergoing treatment.
Is Ben Viglianti, M.D, Ph.D. currently recruiting for clinical trials?
Yes, Ben Viglianti, M.D, Ph.D. is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Ben Viglianti, M.D, Ph.D. has studied deeply?
Yes, Ben Viglianti, M.D, Ph.D. has studied treatments such as [18F]FNP-59.
What is the best way to schedule an appointment with Ben Viglianti, M.D, Ph.D.?
Apply for one of the trials that Ben Viglianti, M.D, Ph.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.